Home › Funds › BRAIDWELL LP › NVCT
BRAIDWELL LP position in NVCT
NUVECTIS PHARMA INC · Health Care
BRAIDWELL LP reported holding 1,573,823 shares of NVCT (NUVECTIS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$33.2M, representing 1.46% of its reported portfolio and ranking #24 among its reported holdings. BRAIDWELL LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How BRAIDWELL LP's NVCT position evolved
BRAIDWELL LP first disclosed a stake in NVCT in Q3 2026 at 1,573,823 shares (US$33.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.57M | $33.24M | New |
About NVCT and 13F data
NVCT (NUVECTIS PHARMA INC) is a Health Care company. 62 other funds we track also report a position in NVCT — the largest reported positions include Soleus Capital Management, L.P. (US$36.1M), TANG CAPITAL MANAGEMENT LLC (US$33.3M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCT
- Soleus Capital Management, L.P. 1.71M sh · $36.13M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.58M sh · $33.33M · Q3 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 793.21K sh · $16.75M · Q3 2026
- Parkman Healthcare Partners LLC 425.35K sh · $8.98M · Q3 2026
- BALDWIN WEALTH PARTNERS LLC/MA 382.01K sh · $8.07M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 323.43K sh · $6.83M · Q3 2026
- Occam Crest Management LP 2.80K sh · $3.09M · Q3 2026
- Avidity Partners Management LP 100.42K sh · $2.12M · Q3 2026
More on BRAIDWELL LP
FAQ
How long has BRAIDWELL LP held NVCT?
BRAIDWELL LP has disclosed NVCT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is BRAIDWELL LP's current position in NVCT?
As of Q3 2026, BRAIDWELL LP holds 1.57M shares of NVCT (NUVECTIS PHARMA INC), valued at $33.24M, representing 1.46% of its reported portfolio and ranking #24.
Has BRAIDWELL LP been buying or selling NVCT?
In the latest 13F filing (Q3 2026), BRAIDWELL LP newly opened its position in NVCT.
Which other funds hold NVCT?
Other major institutional holders of NVCT include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.